Astera Labs (ALAB) Stock Rockets to Record High

Table of Contents Astera Labs (ALAB) shares closed at a record $287.48 Wednesday, marking an extraordinary 18% single-session surge. This followed Tuesday’s impressive 13% advance, bringing the year-to-date gain in 2026 to 73%. Astera Labs, Inc. Common Stock, ALAB The remarkable two-day performance stemmed from encouraging executive remarks at a J.P. Morgan technology, media and communications conference, anticipation surrounding Nvidia earnings, and a wave of analyst price target increases. CEO Jitendra Mohan presented at the conference Tuesday, revealing that the Scorpio product line is projected to become the company’s dominant revenue source by year-end 2026. Mohan estimated the total addressable market for Scorpio X fabric switch technology at approximately $10 billion. He additionally highlighted optical networking as an emerging segment the company plans to pursue. “We are not shy about investing to make sure that we secure our place in the future,” Mohan stated. The semiconductor firm also emphasized its partnership with Nvidia, particularly around the NVLink Fusion system designed for hyperscale customers. Mohan characterized Astera Labs as “the Switzerland of connectivity” — uniquely positioned to integrate across all leading AI infrastructure platforms. Evercore ISI elevated its price target to $297 from $215, pointing to increased hyperscaler demand. JP Morgan increased its objective to $280 while maintaining an Overweight stance. Morgan Stanley adjusted its target to $240 from $210, also with an Overweight rating. TD Cowen raised its forecast to $225 from $140, though it retained a Hold designation. Rothschild & Co Redburn initiated coverage with a Neutral rating and a $153 price objective. Currently, fifteen analysts assign ALAB a Buy rating. Nine recommend Hold. The consensus price target is $233.75 — trailing the current trading price. Morgan Stanley analyst Joseph Moore described Astera as having “one of the best growth rates in our coverage, with multiple product cycles and a very strong position in key AI technology.” The stock’s momentum has been supported by solid quarterly results. Astera Labs delivered Q1 EPS of $0.61, surpassing the consensus estimate of $0.54. Revenue totaled $308.36 million, exceeding the $292.19 million projection. This revenue represents a 93.5% year-over-year jump. Management issued Q2 EPS guidance of $0.68–$0.70, significantly above Street expectations. Morgan Stanley identified Scorpio as “the primary driver of upside” in the first quarter performance. Regarding institutional movements, Csenge Advisory Group established a new stake valued at roughly $1.3 million during Q4. Multiple other institutional investors also increased their holdings. Insider transactions paint a contrasting picture. During the last 90 days, company insiders divested 1.64 million shares valued at approximately $288.7 million. General Counsel Philip Mazzara disposed of 14,076 shares on May 18 at $231.78 per share. The transaction was associated with tax liabilities from equity compensation vesting. The company now commands a market capitalization of $49.28 billion with a price-to-earnings ratio of 194.24. Since pricing its IPO at $36 in March 2024, ALAB has appreciated 699%.